The Wall Street Journal Features Medical Marijuana, Inc. Subsidiary Kannaway® Discussing the Popularity of CBD

SAN DIEGO, Sept. 19, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway® has garnered international news coverage in leading daily news publication, The Wall Street Journal.

A September 12, 2018 article in The Wall Street Journal website titled "Cannabis Comes to Your Coffee and Candy—But Is It Legal?" discusses the recent popularity of cannabidiol (CBD) products around the world, highlighting the inclusion of CBD in many new food and beverage products and the complex legality of CBD in the United States. The article features commentary and cited quotes from a Kannaway® executive explaining that everyday consumers, including moms, are catching on to the popularity of CBD; and how bars and restaurants are also using CBD to enhance their menu offerings and attract more customers.

"Kannaway is honored to be included of this article and the ongoing conversation surrounding CBD and its health and therapeutic benefits," said Kannaway® CEO Blake Schroeder. "We want to continue spreading awareness of the many benefits of CBD and that people of many backgrounds can incorporate it into their everyday lives."

Kannaway® is the first hemp lifestyle network to legally offer hemp-based botanical CBD wellness products. Last month, the company announced that the second quarter of 2018 was the largest-ever sales revenue quarter in its history as a result of its aggressive expansion plans throughout international markets such as Europe. Under new management, Kannaway has grown more than 65 times in revenue since 2016.

The Wall Street Journal is considered the most widely-read periodical in the nation's business and investment community. Information in the paper is also distributed to many Dow Jones outlets, including news services and specialized financial and commodity reports.

About Kannaway®
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:

Public Relations Contact:

Andrew Hard
Chief Executive Officer
CMW Media
P. 858-264-6600
[email protected]
www.cmwmedia.com

View original content:http://www.prnewswire.com/news-releases/the-wall-street-journal-features-medical-marijuana-inc-subsidiary-kannaway-discussing-the-popularity-of-cbd-300715225.html

SOURCE Medical Marijuana, Inc.